Transcranial direct current stimulation in post-stroke aphasia rehabilitation: A systematic review.


Journal

Annals of physical and rehabilitation medicine
ISSN: 1877-0665
Titre abrégé: Ann Phys Rehabil Med
Pays: Netherlands
ID NLM: 101502773

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 07 06 2018
revised: 27 12 2018
accepted: 02 01 2019
pubmed: 21 1 2019
medline: 20 6 2019
entrez: 21 1 2019
Statut: ppublish

Résumé

Transcranial direct current stimulation (tDCS) is a non-invasive tool that induces neuromodulation in the brain. Several studies have shown the effectiveness of tDCS in improving language recovery in post-stroke aphasia. However, this innovative technique is not currently used in routine speech and language therapy (SLT) practice. This systematic review aimed to summarise the role of tDCS in aphasia rehabilitation. We searched MEDLINE via PubMed and Scopus on October 5, 2018 for English articles published from 1996 to 2018. Eligible studies involved post-stroke aphasia rehabilitation with tDCS combined or not with SLT. We retained 5 meta-analyses and 48 studies. Among the 48 studies, 39 were randomised controlled trials (558 patients), 2 prospective studies (56 patients), and 5 case studies (5 patients). Two articles were sub-analyses of a randomised clinical trial. Methods used in these studies were heterogeneous. Only 6 studies did not find a significant effect of tDCS on language performance. As compared with earlier meta-analyses, the 2 latest found significant effects. Evidence from published peer reviewed literature is effective for post-stroke aphasia rehabilitation at the chronic stages. tDCS devices are easy to use, safe and inexpensive. They can be used in routine clinical practice by speech therapists for aphasia rehabilitation. However, further studies should investigate the effectiveness in the subacute post-stroke phase and determine the effect of the lesion for precisely identifying the targeted brain areas. We discuss crucial challenges for future studies.

Sections du résumé

BACKGROUND BACKGROUND
Transcranial direct current stimulation (tDCS) is a non-invasive tool that induces neuromodulation in the brain. Several studies have shown the effectiveness of tDCS in improving language recovery in post-stroke aphasia. However, this innovative technique is not currently used in routine speech and language therapy (SLT) practice.
OBJECTIVE OBJECTIVE
This systematic review aimed to summarise the role of tDCS in aphasia rehabilitation.
METHODS METHODS
We searched MEDLINE via PubMed and Scopus on October 5, 2018 for English articles published from 1996 to 2018. Eligible studies involved post-stroke aphasia rehabilitation with tDCS combined or not with SLT.
RESULTS RESULTS
We retained 5 meta-analyses and 48 studies. Among the 48 studies, 39 were randomised controlled trials (558 patients), 2 prospective studies (56 patients), and 5 case studies (5 patients). Two articles were sub-analyses of a randomised clinical trial. Methods used in these studies were heterogeneous. Only 6 studies did not find a significant effect of tDCS on language performance. As compared with earlier meta-analyses, the 2 latest found significant effects.
CONCLUSION CONCLUSIONS
Evidence from published peer reviewed literature is effective for post-stroke aphasia rehabilitation at the chronic stages. tDCS devices are easy to use, safe and inexpensive. They can be used in routine clinical practice by speech therapists for aphasia rehabilitation. However, further studies should investigate the effectiveness in the subacute post-stroke phase and determine the effect of the lesion for precisely identifying the targeted brain areas. We discuss crucial challenges for future studies.

Identifiants

pubmed: 30660671
pii: S1877-0657(19)30010-7
doi: 10.1016/j.rehab.2019.01.003
pii:
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

104-121

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

Elisa Biou (E)

EA4136 handicap activity cognition health, university of Bordeaux, 33000 Bordeaux, France; Institut universitaire des sciences de la réadaptation, university of Bordeaux, 33000 Bordeaux, France.

Hélène Cassoudesalle (H)

EA4136 handicap activity cognition health, university of Bordeaux, 33000 Bordeaux, France; Department of physical medicine and rehabilitation, CHU de Bordeaux, 33000 Bordeaux, France.

Mélanie Cogné (M)

EA4136 handicap activity cognition health, university of Bordeaux, 33000 Bordeaux, France; Department of physical medicine and rehabilitation, CHU de Bordeaux, 33000 Bordeaux, France.

Igor Sibon (I)

INCIA, CNRS UMR5287, university of Bordeaux, 33400 Talence, France; Stroke unit, clinical neurosciences department, CHU de Bordeaux, 33076 Bordeaux, France.

Isabelle De Gabory (I)

Stroke unit, clinical neurosciences department, CHU de Bordeaux, 33076 Bordeaux, France.

Patrick Dehail (P)

EA4136 handicap activity cognition health, university of Bordeaux, 33000 Bordeaux, France; Institut universitaire des sciences de la réadaptation, university of Bordeaux, 33000 Bordeaux, France; Department of physical medicine and rehabilitation, CHU de Bordeaux, 33000 Bordeaux, France.

Jerome Aupy (J)

Institute of neurodegenerative diseases, CNRS UMR 5293, University of Bordeaux, 33000 Bordeaux, France.

Bertrand Glize (B)

EA4136 handicap activity cognition health, university of Bordeaux, 33000 Bordeaux, France; Institut universitaire des sciences de la réadaptation, university of Bordeaux, 33000 Bordeaux, France; Department of physical medicine and rehabilitation, CHU de Bordeaux, 33000 Bordeaux, France; Institute of neurodegenerative diseases, CNRS UMR 5293, University of Bordeaux, 33000 Bordeaux, France. Electronic address: bertrand.glize@chu-bordeaux.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH